Shu-Ti Lin

Publications

• Mini Review   
  Therapeutic Response Monitoring: Minimal Residual Disease Testing in Cancer Management
  Author(s): Shu-Ti Lin and Chen Yeh*
  
  Clinicians are tasked with monitoring drug treatment effects to ensure safe and effective therapy. While monitoring response to treatment is vital in cancer management, reliable biomarkers for non-invasive, longitudinal, and real-time evaluations are still challenging to find. Often, monitoring is done inappropriately—too much, too little, or at the wrong time-and isn’t always targeted at clinically useful parameters. Moreover, monitoring involves more than objective laboratory tests; it requires patient participation through reporting clinical response signals. Innovative cancer research is focused on identifying biomarkers with diagnostic, prognostic, predictive, and therapeutic value. Developing accurate and robust cancer biomarkers is important for precision diagnostics and personalized treatment. These biomarkers should be used to assess therapeutic interven.. Read More»
  

  Abstract PDF